Diabetes Mellitus Type 2 News

• WHO Provides Insulin Pens for Diabetes to Ukraine Hospitals The World Health Organization is delivering insulin pens to hospitals throughout Ukraine for those with diabetes as Russia continues its invasion.
  Medscape Medical News, September 02, 2022
• Exercise May Counteract Genetics for Gestational Diabetes Researchers concluded that physical activity early in pregnancy is associated with reduced risk for gestational diabetes and may help women who are at high risk.
  MDedge News, September 02, 2022
• SGLT2 Inhibitors Lower NAFLD, HCC Risks Over DPP4i Sodium glucose cotransporter 2 inhibitors (SGLT2is) lowered the risk of nonalcoholic fatty liver disease and hapatocellular carcinoma versus dipeptidyl-peptidase-4 inhibitors (DPP4is).
  First Look, September 01, 2022
• What's Best Way to Estimate Risk for Type 2 Diabetes? None of the anthropometric indices commonly used in clinical practice are superior to waist circumference or BMI for predicting the risk for developing type 2 diabetes, new data suggest.
  Medscape Medical News, September 01, 2022
• Real-World Findings Support RASi Continuation in Advanced CKD Discontinuing renin-angiotensin-system inhibitors in people with type 2 diabetes and chronic kidney disease can lead to a greater risk of adverse outcomes.
  First Look, August 31, 2022
• Do People Living With HIV Age Prematurely? People living with HIV may develop cardiovascular disease and hypertension earlier and be increasingly prone to chronic kidney disease, researchers in the United Kingdom report.
  Medscape Medical News, August 29, 2022
• ESC 2022 Albuminuria Linked to Higher CVD Risk in Diabetes An analysis of more than 74,000 Danish people with type 2 diabetes showed an elevated CVD event rate in those with albuminuria.
  Medscape Medical News, August 28, 2022
• ESC 2022 Dapagliflozin's HFpEF Benefit Recasts HF Treatment: DELIVER Results from DELIVER made dapagliflozin the third SGLT2 inhibitor to benefit patients with HFpEF, cementing a new, ejection fraction-agnostic management approach.
  MDedge News, August 27, 2022
• ESC 2022 Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart failure, researchers reported.
  Medscape Medical News, August 27, 2022
• Nutrition Gets Short Shrift in Battle Against Chronic Disease In a Medscape survey, physicians — even endocrinologists and cardiologists — said they don't have the time or the confidence in their knowledge to deliver nutrition counseling.
  Medscape Medical News, August 26, 2022
• Metformin, Testosterone Replacement Linked to Reduced Cancer Risk The use of the diabetes drug and testosterone replacement therapy, independently and in combination, were linked to reductions in the incidence of prostate and colorectal cancers.
  Medscape Medical News, August 26, 2022
• ESC 2022 NSAIDs Linked to Heart Failure Risk in Diabetes A Danish case-crossover study found that NSAID use increased heart failure risks 50% in patients with diabetes.
  MDedge News, August 25, 2022
• Metformin Fails as Early COVID-19 Treatment While cholesterol levels in American adults have improved overall in the past decade, disparities in control have emerged in a new analysis.
  Medscape Medical News, August 25, 2022
• Early Menopause Linked With Increased Risk of Heart Problems In a recent analysis of national health data, the risks for incident heart failure and incident atrial fibrillation increased as age at menopause decreased.
  Medscape Medical News, August 25, 2022
• Blood Pressure TTR Predicts Cardiovascular Outcomes in Diabetes In patients with type 2 diabetes and hypertension, time in target range for systolic blood pressure may be useful to assess blood pressure control and guide treatment to reduce cardiovascular risk.
  First Look, August 22, 2022
• Exercise May Help Diet-Resistant Women With Obesity In women with more lower-body fat than abdominal fat who have a low response to caloric restriction, exercise improved body composition, skeletal muscle mitochondria, and metabolism in a new study.
  Medscape Medical News, August 22, 2022
• Are Artificial Sweeteners Really Harmless? New research suggests that sugar substitutes are not metabolically inert but can alter the gut microbiome in a way that can influence blood glucose levels.
  Medscape Medical News, August 19, 2022
• Residential Greenness May Protect Against Diabetic Retinopathy Findings point to importance of promoting greenness exposure.
  First Look, August 12, 2022
• Atherosclerosis and Diabetes Synergistic, Deadlier in South Asians South Asians, from India and elsewhere on the subcontinent, living in America have a higher risk of dying from atherosclerotic disease plus type 2 diabetes than other Americans.
  First Look, August 11, 2022
• FDA Says Found Possible Carcinogen in Certain Samples of Merck's Januvia The Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia, were contaminated with a possible carcinogen.
  Reuters Health Information, August 09, 2022